The binding ratios in PSP in FFPE were significantly lower than those in AD, the authors explain this with the lower tau load in PSP compared to AD and to different binding affinities in 4R- and 3R/4R-tauopathies [175]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.